Incidence and factors associated with extrapulmonary cryptococcosis among persons with HIV infection in Los Angeles County

AIDS

Volumn 11, Issue 5, 1997, Pages 673-679

  Sorvillo, Frank ^e   Beall, Gildon ^a   Turner, Paul A ^b   Beer, Victor L ^c   Kovacs, Andrea A ^d   Kerndt, Peter R ^e  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c Beer Medical Group   (United States)

^d LAC USC MEDICAL CENTER   (United States)

^e LOS ANGELES COUNTY DEPARTMENT OF HEALTH SERVICES   (United States)

Author keywords

Cryptococcosis; Epidemiology; HIV

Indexed keywords

ANTIFUNGAL AGENT; CD4 ANTIGEN;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CRYPTOCOCCOSIS; DATA ANALYSIS; DEMOGRAPHY; DISEASE TRANSMISSION; EARLY DIAGNOSIS; ETHNIC GROUP; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SEASONAL VARIATION; SEX DIFFERENCE; SURVIVAL; UNITED STATES; WINTER;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CRYPTOCOCCOSIS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; LOS ANGELES; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0030936811     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199705000-00016     Document Type: Article

References (26)

1. Currie BP, Casadevall A: Estimation of the prevalence of crypinfection among patients infected with the human immunodeficiency virus in New York City. J Infect Dis 1994, 19:1029-1033.
2. Kovacs JA, Kovacs AA, Polis M, et al.: Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985, 103:533-538.
3. Chuck SL, Sande MA: Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989, 321:794-799.
4. Shimizu RY, Howard DH, Clancy MN: The variety of Cryptococcus neoformans in patients with AIDS [letter]. J Infect Dis 1986, 154:1042.
5. Kaplan JE, Masur H, Jaffe HW, Holmes KK: Reducing the impact of opportunistic infections in patients with HIV infection. JAMA 1995, 274: 347-348.
6. Levitz SM: The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. J Infect Dis 1991, 13:1163-1169.
7. Emmons CW: Prevalence of Cryptococcus neoformans in pigeon habitats. Public Health Rep 1960, 75:362-364.
8. Pal M, Mebrotra BS: Studies on the isolation of Cryptococcus neoformans from fruits and vegetables. Mykosen 1984, 28:200-205.
9. Perfect JR: Cryptococcosis. Infect Dis Clin North Am 1989, 3:77-102.
10. Green JR, Bulmer GS: Gastrointestinal inoculation of Cryptococcus neoformans in mice. Sabouraudia 1979, 17:233-240.
11. Glaser JB, Garden A: Inoculation of cryptococcosis without transmission of the acquired immunodeficiency syndrome [letter]. N Engl J Med 1985, 313:264.
12. Currie BP, Freundlich LF, Casadevall A: Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J Clin Microbiol 1994, 32:1188-1192.
13. Larizo KM, Buehler JW, Chamberland ME, et al.: Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992, 263:1798-1805.
14. Centers for Disease Control: Revision of the CDC case definition for acquired immunodefiecy syndrome. MMWR 1987, 36 (suppl 1S):1-15.
15. Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research. Principles and Quantitative Methods. Belmont: Lifetime Learning Publications; 1982:336-337.
16. Greenland S: Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989, 79:340-349.
17. Mohr JA, Long H, McKown BA, Muchmore HG: In vitro susceptibility of Cryptococcus neoformans to steroids. Sabouraudia 1972, 10:171-172.
18. Williams PL, Sable DL, Mendez P, Smyth LI: Symptomatic coccidioidomycois following a severe natural dust storm. An outbreak at the naval Air Station, Lemoore, California. Chest 1979, 76:566-570.
19. Westrom L, Svenson L, Wolner-Hansen P, Mardh PA: Chlamydial and gonococcal infection in a defined population of women. Scan J Infect Dis 1982, 32:157-162.
20. Larsen RA, Bozette S, McCutchan JA, et al.: Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. Ann Intern Med 1989, 111:125-128.
21. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JE: Predictive value of CD4 lymphocyte number for the development of opportunistic indections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 1991, 4:770-776.
22. Quagliarello VJ, Viscoli C, Horowitz RI: Primary prevention of cryptococcal meaningitis by fluconazole in HIV-infected patients. Lancet 1995, 345:548-552.
23. Newton JA, Jr, Lasker SA, Bone WD, et al.: Weekly fluconazole for the suppression of recurrent thrush in HIV-seropositive patients: impact on the incidence of disseminated cryptococcal infection [letter]. AIDS 1995, 9:1286-1287.
24. United States Public Health Service/Infetious Disease Society of America frevention of Opportunistic Infections Working Group: USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. Clin Infect Dis 1995, 21 (suppl 1):S32-S43.
25. Ruiz A, Fromtiling RA, Bulmer GS: Distribution of Cryptococcus neoformans in a natural site. Infect Immun 1981, 31:560-563.
26. Holmberg K, Meyer RD: Fungal infections in patients with AIDS and AIDS-related complex. Scand J Infect Dis 1986, 18:179-192.